Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2011-3-4
pubmed:abstractText
In the hematopoietic hierarchy, only stem cells are thought to be capable of long-term self-renewal. Erythroid progenitors derived from fetal or adult mammalian hematopoietic tissues are capable of short-term, or restricted (10(2)- to 10(5)-fold), ex vivo expansion in the presence of erythropoietin, stem cell factor, and dexamethasone. Here, we report that primary erythroid precursors derived from early mouse embryos are capable of extensive (10(6)- to 10(60)-fold) ex vivo proliferation. These cells morphologically, immunophenotypically, and functionally resemble proerythroblasts, maintaining both cytokine dependence and the potential, despite prolonged culture, to generate enucleated erythrocytes after 3-4 maturational cell divisions. This capacity for extensive erythroblast self-renewal is temporally associated with the emergence of definitive erythropoiesis in the yolk sac and its transition to the fetal liver. In contrast, hematopoietic stem cell-derived definitive erythropoiesis in the adult is associated almost exclusively with restricted ex vivo self-renewal. Primary primitive erythroid precursors, which lack significant expression of Kit and glucocorticoid receptors, lack ex vivo self-renewal capacity. Extensively self-renewing erythroblasts, despite their near complete maturity within the hematopoietic hierarchy, may ultimately serve as a renewable source of red cells for transfusion therapy.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1528-0020
pubmed:author
pubmed:copyrightInfo
© 2011 by The American Society of Hematology
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2708-17
pubmed:dateRevised
2011-5-16
pubmed:meshHeading
pubmed-meshheading:21127173-Animals, pubmed-meshheading:21127173-Cell Differentiation, pubmed-meshheading:21127173-Cell Division, pubmed-meshheading:21127173-Cell Proliferation, pubmed-meshheading:21127173-Cell Size, pubmed-meshheading:21127173-Cell Survival, pubmed-meshheading:21127173-Cells, Cultured, pubmed-meshheading:21127173-Cytokines, pubmed-meshheading:21127173-Dexamethasone, pubmed-meshheading:21127173-Erythroblasts, pubmed-meshheading:21127173-Fetus, pubmed-meshheading:21127173-Humans, pubmed-meshheading:21127173-Liver, pubmed-meshheading:21127173-Mammals, pubmed-meshheading:21127173-Mice, pubmed-meshheading:21127173-Mice, Inbred C57BL, pubmed-meshheading:21127173-Phenotype, pubmed-meshheading:21127173-Proto-Oncogene Proteins c-kit, pubmed-meshheading:21127173-Receptors, Erythropoietin, pubmed-meshheading:21127173-Receptors, Glucocorticoid, pubmed-meshheading:21127173-Stem Cells, pubmed-meshheading:21127173-Yolk Sac
pubmed:year
2011
pubmed:articleTitle
Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.
pubmed:affiliation
Department of Pediatrics, Center for Pediatric Biomedical Research, University of Rochester Medical Center, Rochester, NY 14642, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural